Fish oil supplementation during chemotherapy increases posterior time to tumor progression in colorectal cancer

Nutrition and Cancer

Volumn 68, Issue 1, 2016, Pages 70-76

  De Quadros Camargo, Carolina ^a   Mocellin, Michel Carlos ^a   De Aguiar Pastore Silva, Juliana ^b   De Souza Fabre, Maria Emilia ^c   Nunes, Everson Araújo ^a   De Moraes Trindade, Erasmo Benicio Santos ^c  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b A C CAMARGO CANCER CENTER   (Brazil)

^c Oncology Research Center   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARCINOEMBRYONIC ANTIGEN; DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID;

ADULT; ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER SURVIVAL; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; MULTIPLE CYCLE TREATMENT; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; AGED; BLOOD; COLORECTAL NEOPLASMS; DIETARY SUPPLEMENT; DISEASE COURSE; MORTALITY; TIME FACTOR;

ADULT; AGED; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; DIETARY SUPPLEMENTS; DISEASE PROGRESSION; FEMALE; FISH OILS; HUMANS; MALE; MIDDLE AGED; TIME FACTORS;

EID: 84957972830     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2016.1115097     Document Type: Article

References (21)

1. GLOBOCAN. 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. [Internet]. Available from: http://globocan.iarc.fr
2. Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, et al.: SEER Cancer Statistics Review, 1975-2011. Bethesda, MD: National Cancer Institute, 2014.
3. Andre N, and, Schmiegel W.: Chemoradiotherapy for colorectal cancer. Gut 54, 1194-202, 2005.
4. Roynette CE, Calder PC, Dupertuis YM, and, Pichard C.: n-3 polyunsaturated fatty acids and colon cancer prevention. Clinical Nutrition 23, 139-151, 2004.
5. Hardman WE.: (n-3) fatty acids and cancer therapy. The Journal of Nutrition 134 (12 Suppl.), 3427S-3430S, 2004.
6. Berquin IM, Edwards IJ, and, Chen YQ.: Multi-targeted therapy of cancer by omega-3 fatty acids. Cancer Letters 269, 363-377, 2008.
7. Zajdel A, Wilczok A, Latocha M, Tarkowski M, Kokocinska M, et al.: Polyunsaturated fatty acids potentiate cytotoxicity of cisplatin in A549 cells. Acta Poloniae Pharmaceutica 71, 1060-1065, 2014.
8. Germain E, Chajes V, Cognault S, Lhuillery C, and, Bougnoux P.: Enhancement of doxorubicin cytotoxicity by polyunsaturated fatty acids in the human breast tumor cell line MDA-MB-231: relationship to lipid peroxidation. International Journal of Cancer/Journal international du cancer 75, 578-583, 1998.
9. Calviello G, Serini S, Piccioni E, and, Pessina G.: Antineoplastic effects of n-3 polyunsaturated fatty acids in combination with drugs and radiotherapy: preventive and therapeutic strategies. Nutrition and Cancer 61, 287-301, 2009.
10. Benais-Pont G, Dupertuis YM, Kossovsky MP, Nouet P, Allal AS, et al.: Omega-3 polyunsaturated fatty acids and ionizing radiation: combined cytotoxicity on human colorectal adenocarcinoma cells. Nutrition 22, 931-939, 2006.
11. Cai F, Sorg O, Granci V, Lecumberri E, Miralbell R, et al.: Interaction of omega-3 polyunsaturated fatty acids with radiation therapy in two different colorectal cancer cell lines. Clinical Nutrition 33, 164-170, 2014.
12. Trabal J, Leyes P, Forga M, and, Maurel J.: Potential usefulness of an EPA-enriched nutritional supplement on chemotherapy tolerability in cancer patients without overt malnutrition. Nutricion Hospitalaria 25, 736-740, 2010.
13. de Aguiar Pastore Silva J, Emilia de Souza Fabre M, and, Waitzberg DL.: Omega-3 supplements for patients in chemotherapy and/or radiotherapy: a systematic review. Clinical Nutrition 34, 359-366, 2015.
14. Silva Jde A, Trindade EB, Fabre ME, Menegotto VM, Gevaerd S, et al.: Fish oil supplement alters markers of inflammatory and nutritional status in colorectal cancer patients. Nutrition and Cancer 64, 267-273, 2012.
15. Mocellin MC, Pastore e Silva J de A, Camargo C de Q, Fabre ME, Gevaerd S, et al.: Fish oil decreases C-reactive protein/albumin ratio improving nutritional prognosis and plasma fatty acid profile in colorectal cancer patients. Lipids 48, 879-888, 2013.
16. Bougnoux P, Hajjaji N, Ferrasson MN, Giraudeau B, Couet C, et al.: Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trial. British Journal of Cancer 101, 1978-1985, 2009.
17. Baracos VE, Mazurak VC, and, Ma DW.: n-3 Polyunsaturated fatty acids throughout the cancer trajectory: influence on disease incidence, progression, response to therapy and cancer-associated cachexia. Nutrition Research Reviews 17, 177-192, 2004.
18. Merendino N, Costantini L, Manzi L, Molinari R, D'Eliseo D, et al.: Dietary omega-3 polyunsaturated fatty acid DHA: a potential adjuvant in the treatment of cancer. BioMed Research International 2013, 310186, 2013.
19. Hardman WE, Munoz J, Jr., and, Cameron I.: Role of lipid peroxidation and antioxidant enzymes in omega 3 fatty acids induced suppression of breast cancer xenograft growth in mice. Cancer Cell International 2, 10, 2002.
20. Bougnoux P, Hajjaji N, Maheo K, Couet C, and, Chevalier S.: Fatty acids and breast cancer: sensitization to treatments and prevention of metastatic re-growth. Progress in Lipid Research 49, 76-86, 2010.
21. Murphy RA, Mourtzakis M, Chu QS, Baracos VE, Reiman T, et al.: Supplementation with fish oil increases first-line chemotherapy efficacy in patients with advanced nonsmall cell lung cancer. Cancer 117, 3774-3780, 2011.